Diabetes & Endocrinology Archives - Page 3 of 6

Diabetes & Endocrinology

Diabetes & Endocrinology

Eli Lilly Drug Zepbound Slashes Diabetes Risk in Obese Users

BlackDoctor Pro Editors
12/03/2024

Eli Lilly Drug Zepbound Reduced Diabetes Risk in Obese Users

Zepbound reduces type 2 diabetes risk by 90% in obese prediabetic patients, showing potential as a preventive treatment.

Diabetes & Endocrinology

BlackDoctor Pro Editors
12/02/2024

Biden Wants Medicare and Medicaid Cover GLP-1s

Biden proposes Medicare/Medicaid cover expensive GLP-1 obesity drugs. Potential impact on 7.4 million patients. Awaiting new administration's approval.

Diabetes & Endocrinology

BlackDoctor Pro Editors
10/31/2024

Semaglutide Drugs Might Help Lower Diabetic Alzheimer’s Risk

Semaglutide may lower Alzheimer's risk in diabetics, suggesting neuroprotective benefits. Explore potential shifts in dementia management.

Cardiology

BlackDoctor Pro Editors
10/01/2024

The Link Between Body Roundness Index and Cardiovascular Disease Risk

Higher Body Roundness Index trajectory increases cardiovascular disease risk. Explore implications for Black patients' risk assessment. Read the full analysis.

Diabetes & Endocrinology

BlackDoctor Pro Editors
09/26/2024

Novo Nordisk Questioned Over Ozempic Prices

Novo Nordisk's high Ozempic prices impact access for underserved populations. Discuss cost-reduction strategies with PBMs. Read more for implications.

Diabetes & Endocrinology

BlackDoctor Pro Editors
09/13/2024

How Ozempic and Mounjaro Help People With Type 1 Diabetes, Too

Ozempic and Mounjaro aid weight loss, improve blood sugar in type 1 diabetes, potentially reducing obesity-related complications. Read further insights.

Diabetes & Endocrinology

BlackDoctor Pro Editors
08/28/2024

FDA Expands Approval of This Device for Type 2 Diabetes

FDA approves Omnipod 5 for Type 2 diabetes; automates insulin delivery, potentially reducing disease management burden for Black patients.

Diabetes & Endocrinology

BlackDoctor Pro Editors
08/06/2024

Diabetes: What It Is and What Black People Need to Know

Diabetes disproportionately affects Black communities, driven by genetic, socioeconomic, and healthcare disparities. Addressing these can improve outcomes. Read more for comprehensive strategies.

Diabetes & Endocrinology

BlackDoctor Pro Editors
07/05/2024

Semaglutide Linked to Sudden Vision Change NAION

Semaglutide use may increase NAION risk in T2D, obesity patients. Impacts vision health equity. Explore management strategies further.

Cardiology

BlackDoctor Pro Editors
06/26/2024

Wegovy Helps Improve Symptoms in Heart Failure Patients

Semaglutide improves heart failure symptoms, benefiting Black patients disproportionately affected. Explore implications for heart health management. Read more.

Diabetes & Endocrinology

BlackDoctor Pro Editors
05/28/2024

Semaglutide Shows Boost in Kidney Health in Obese Patients

Semaglutide reduces kidney complications in obese patients, potentially improving care for Black populations with elevated obesity rates. Read more.

Cardiology

BlackDoctor Pro Editors
05/13/2024

Metabolic Syndrome Independently Linked to Breast Cancer

Metabolic syndrome heightens breast cancer mortality risk in postmenopausal women. Read more on implications for patient management.

AI-Powered Search. Human-Created Content.

What is the most critical factor in managing vasomotor symptoms?

Early intervention

Non-hormonal treatments

Ethnic-specific research

Cardiac health monitoring

Expert Medical Insights, Straight to Your Inbox

Insights That Keep Black Healthcare Leaders at the Forefront

By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.

Empowering Culturally-Sensitive Healthcare Professionals

BlackDoctor Pro is an online destination created specifically for Black doctors and culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies. We are committed to empowering HCPs with the knowledge, resources, and support needed to achieve exceptional health outcomes in black communities.